Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699943 · ClinicalTrials.gov registry record · NA
Autologous Bone Marrow Concentrate in Treatment of Erectile Dysfunction.
A NA study of Erectile Dysfunction, sponsored by Creative Medical Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03699943 is a NA study of Erectile Dysfunction that has completed, run by Creative Medical Health. The registered enrollment target is 40 participants, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03699943, a NA study of Erectile Dysfunction, has completed, sponsored by Creative Medical Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study assessed the safety and efficacy of autologous bone marrow concentrate and injected intra-cavernously into patients with erectile dysfunction (ED). Specifically, this study will evaluate ED treatment \>18 year old men, a demographic where the etiology of ED is attributable primarily to the loss of corporal smooth muscle in the penis. Study endpoints will evaluate the safety and efficacy of intracavernosal bone marrow concentrate administration for treating ED patients.
Conditions Studied
Interventions
- PROCEDURE CaverStem
Study Locations (1)
California
- Harbor - UCLA Medical Center - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-12-08 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03699943
The ClinicalTrials.gov registry entry for NCT03699943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (83% lower). The listed sponsor is Creative Medical Health, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which CaverStem is the first listed.
NCT03699943 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03699943 about?
NCT03699943 is a clinical study titled "Autologous Bone Marrow Concentrate in Treatment of Erectile Dysfunction.". This study assessed the safety and efficacy of autologous bone marrow concentrate and injected intra-cavernously into patients with erectile dysfunction (ED). Specifically, this study will evaluate ED treatment \>18 year old men, a demographic where the etiology of ED is attributable primarily to th...
What is the current status of trial NCT03699943?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-12-08. Estimated completion is 2019-08-31.
What conditions does trial NCT03699943 study?
This clinical trial studies the following conditions: Erectile Dysfunction.
What interventions are being tested in trial NCT03699943?
The interventions under investigation include: CaverStem (PROCEDURE).
Who is sponsoring clinical trial NCT03699943?
This trial is sponsored by Creative Medical Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03699943 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.